Spectrazyme
Recalling firm: Metagenics, Inc.
Why it was recalled
Metagenics is recalling Spectrazyme because their raw material supplier informed them that enzymes in the blend may contain the antibiotic chloramphenicol.
The exact product
Spectrazyme, 180 count, 60 count, 12 bottles/case, 20000 tablets/box, 14000 capsules/pail.
Check the codes
Compare these FDA-provided codes, lot numbers or dates with the product you have.
Match the product, size and code together. A similar name alone does not identify your batch.
Original FDA code information
Lot Code: 0413083 0513007 0513008
Recall details
- Recall number
- F-0138-2014
- Event ID
- 66511
- FDA status
- Terminated
- Initiated
- Oct 11, 2013
- Reported
- Nov 20, 2013
- Classified
- Nov 12, 2013
- Terminated
- Mar 3, 2014
- Quantity
- 1,171,300 units
- Location
- Aliso Viejo, CA, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
Where it was distributed
Nationwide in US and worldwide to Japan, Taiwan, Belgium, and Canada
FDA source record · F-0138-2014
Data updated September 16, 2026. View official FDA data ↗
A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.